AstraZeneca PLC
Novo Nordisk cuts 2025 guidance as drug copycats hit Wegovy sales, posts first-quarter profit beat
Flags with the logos of Danish drugmaker Novo Nordisk, maker of the blockbuster diabetes and weight-loss treatments Ozempic and Wegovy are pictures while the company presents the annual report at Novo Nordisk in Bagsvaerd, Denmark, on February 5, 2025. Mads Claus Rasmussen | Afp | Getty Images Novo Nordisk on Wednesday reported a better-than-expected rise in […]
Read More
London’s FTSE 100 is on track for record-breaking gains — and market watchers think it may have further to run
A member of staff next to a trading board at the London Stock Exchange on April 25, 2025. Carl Court | Getty Images While global markets have been gripped by turbulence in the wake of U.S. President Donald Trump’s seesawing tariffs policies, British stocks have enjoyed a bumper rally. London’s FTSE 100 index, which has […]
Read More
European stocks open higher on China-U.S. optimism
European stocks opened higher on Friday, as investors assessed a signal that China is seeking trade negotiations will the U.S. The Stoxx 600 index jumped 0.88% in early deals, led by mining stocks, up 2.5%, while banks climbed 1.7%. Most markets were closed on Thursday for the May 1 holiday. London’s FTSE 100 ended a choppy […]
Read More
Europe stocks open higher amid earnings deluge; autos gain on tariff hopes
European stock markets opened higher on Wednesday, as investors pored through another slew of earnings along with euro zone economic growth data. The Stoxx 600 index was up 0.44% at 8:08 a.m. in London after notching a sixth straight positive session on Tuesday, extending its longest winning streak since January. The U.K.’s FTSE 100 meanwhile closed higher […]
Read More
Europe stocks open higher; Volvo Cars sheds 10%, Porsche falls 7% after earnings
AstraZeneca shares fall despite earnings growth AstraZeneca’s production plant in Snackviken, Sweden. Roland Magnusson | iStock Editorial | Getty Images British pharmaceutical giant AstraZeneca was 4% lower shortly after the opening bell, after the company posted its first-quarter earnings update. On Tuesday morning, AstraZeneca reported a 10% year-on-year rise in total revenue, which hit $13.59 […]
Read More
Eli Lilly’s weight loss pill succeeds in first late-stage trial on diabetes patients
Eli Lilly on Thursday said its daily obesity pill met the company’s goals in the first of several late-stage trials, helping Type 2 diabetes patients lower their blood sugar and body weight and showing safety on par with popular injections on the market. The trial results are among the pharmaceutical industry’s most closely watched studies […]
Read More
Pharmaceutical stocks fall as Trump doubles down on tariffs threat
The Lilly Biotechnology Center in San Diego, California, on March 1, 2023. Mike Blake | Reuters Shares of drugmakers fell on Wednesday after President Donald Trump doubled down on plans to impose tariffs on pharmaceuticals imported into the U.S. Shares of U.S.-based companies Eli Lilly, AbbVie, Bristol Myers Squibb and Regeneron all fell about 4% […]
Read More
The biggest winners and losers in Europe as Trump announces sweeping tariffs
U.S. President Donald Trump stands, after delivering remarks on tariffs, in the Rose Garden at the White House in Washington, D.C., U.S., April 2, 2025. Leah Millis | Reuters Global markets, businesses and long-standing geopolitical relationships were thrown into disarray on Thursday, the day after U.S. President Donald Trump’s tariff policy — and Europe was not […]
Read More
Pharma tariff relief likely short-lived with sector-specific duties on the horizon
Boxes of Novo Nordisk’s weight-loss drug Wegovy in Oslo, Norway, Nov. 21, 2023. Victoria Klesty | Reuters Pharmaceutical companies breathed a sigh of relief Wednesday after U.S. President Donald Trump revealed that they would not be subject to reciprocal tariffs — but that reprieve could prove fleeting as the White House moves ahead with plans […]
Read More
Trump’s tariffs are a new challenge for Big Pharma. Here are the best-positioned stocks
Long-standing trade agreements have largely sheltered the pharmaceutical industry from tariffs but President Donald Trump’s goal of bringing manufacturing back to the United States has put the industry in the administration’s crosshairs. Trump first floated the idea of imposing tariffs of as much as 25% on imported pharmaceuticals in mid-February. Since then, he has repeated […]
Read More